MedPath

Clinical observation of shuitong and Shuijin points to inhibit sufentanil-induced cough

Phase 1
Conditions
Complications from sufentanil
Registration Number
ITMCTR2100005117
Lead Sponsor
Rizhao Central Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Heart and lung functions were normal, no history of drug abuse, no history of long-term use of opioids, and tolerance to surgical anesthesia.

Exclusion Criteria

Preoperative temperature > 38.5?, history of upper respiratory tract infection nearly 2 weeks before surgery,, chronic obstructive pulmonary disease, asthma, chest surgery, history of hypertension, smoking, use of hormones, bronchodilator drugs, vasoinvertase inhibitors

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Choking cough cases;Severity of coughing;
Secondary Outcome Measures
NameTimeMethod
Changes in hemodynamics;Number of chest wall stiffness cases;
© Copyright 2025. All Rights Reserved by MedPath